Sharps Technology shareholders approve issuance of 56M shares upon warrant exercises at special meeting

Sharps Technology Inc.

Special meeting quorum of 66.9% achieved (17,779,090 of 26,600,848 shares present); all four proposals passed.
Annemarie Tierney elected director with 17,770,289 votes for (99.95% of votes cast).
Approved issuance of 49,673,120 shares upon exercise of Cryptocurrency Pre-Funded and Stapled Warrants; 17,750,927 for, 27,713 against.
Approved issuance of 6,321,367 shares to Sol Markets; 17,743,259 for, 35,546 against.
Adjournment proposal approved with 16,802,916 for, 51,835 against, 924,339 abstentions.

item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-25-018148
form_type: 8-K
ticker: STSS
cik: 0001737995
company_name: Sharps Technology Inc.
filed_at: 2025-10-15T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.284956+00:00
generated_at: 2026-05-17T03:46:15.547856+00:00
sec_items: ["5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-25-018148
json_url: https://secwatch.observer/filing/0001493152-25-018148.json
markdown_url: https://secwatch.observer/filing/0001493152-25-018148.md
text_url: https://secwatch.observer/filing/0001493152-25-018148.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1737995/000149315225018148/0001493152-25-018148-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1737995/000149315225018148/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-25-018148

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.